Literature DB >> 33533662

Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit.

Pietro Quaglino1, Paolo Fava1, Matteo Brizio1, Elena Marra1, Marco Rubatto1, Martina Merli1, Luca Tonella1, Simone Ribero1, Maria Teresa Fierro1.   

Abstract

Entities:  

Keywords:  COVID-19; advanced metastatic melanoma; targeted therapies

Year:  2021        PMID: 33533662      PMCID: PMC7874884          DOI: 10.2217/fon-2020-0997

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  5 in total

Review 1.  Melanoma Management during the COVID-19 Pandemic Emergency: A Literature Review and Single-Center Experience.

Authors:  Caterina Cariti; Martina Merli; Gianluca Avallone; Marco Rubatto; Elena Marra; Paolo Fava; Virginia Caliendo; Franco Picciotto; Giulio Gualdi; Ignazio Stanganelli; Maria Teresa Fierro; Simone Ribero; Pietro Quaglino
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

2.  Melanomversorgung während eines Jahres Pandemie in Berlin: abnehmende Terminstornierungen trotz zunehmender Besorgnis über COVID-19.

Authors:  Aleksandra Micek; Katharina Diehl; Miriam Teuscher; Marthe-Lisa Schaarschmidt; Bianca Sasama; Jan Ohletz; Guido Burbach; Felix Kiecker; Uwe Hillen; Wolfgang Harth; Wiebke K Peitsch
Journal:  J Dtsch Dermatol Ges       Date:  2022-07       Impact factor: 5.231

3.  Melanoma care during one year pandemic in Berlin: decreasing appointment cancellations despite increasing COVID-19 concern.

Authors:  Aleksandra Micek; Katharina Diehl; Miriam Teuscher; Marthe-Lisa Schaarschmidt; Bianca Sasama; Jan Ohletz; Guido Burbach; Felix Kiecker; Uwe Hillen; Wolfgang Harth; Wiebke K Peitsch
Journal:  J Dtsch Dermatol Ges       Date:  2022-06-06       Impact factor: 5.231

4.  Topological network based drug repurposing for coronavirus 2019.

Authors:  Mahnaz Habibi; Golnaz Taheri
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

5.  Novel natural inhibitors targeting B-RAF(V600E) by computational study.

Authors:  Bo Wu; Zhiyun Zhang; Gaojing Dou; Xiaye Lv; Junliang Ge; Hongyu Wang; Haoqun Xie; Dong Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.